expected news flow........tick tock punters! Suspect Canada approval next.
✓ Govt contract signed and expansion of Australian customer base – Q4 2019
✓ First UK sales of Enterprise Dementia product - Q4 2019
✓ First NZ sales of Enterprise Dementia product - Q4 2019
✓ FDA de Novo pre-sub supplement completed for Adult product – Q1 2020
✓ Philips Healthcare programme update - Q1 2020
• Launch Home care dementia product in Australia and Europe - 2H 2020
• TGA and CE Mark submission for Pre-verbal Children product – CY 2021
• FDA de Novo clearance submitted for US market – CY 2021
• Government trial outcomes research report - Q2 2021
• Launch Pre-verbal Children product in Australia and UK- CY 2021
• US Adult product launch - expected CY 2021/early 2022
N.B. COVID 19 is impacting global clinical trials – the above timings have been adapted based on best current estimates
PainChek General Discussion, page-17692
-
- There are more pages in this discussion • 2,721 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
